company background image
ACHV

Achieve Life Sciences NasdaqCM:ACHV Stock Report

Last Price

US$3.34

Market Cap

US$32.3m

7D

-20.5%

1Y

-61.3%

Updated

28 Sep, 2022

Data

Company Financials +
ACHV fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance0/6
Financial Health4/6
Dividends0/6

ACHV Stock Overview

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom.

Achieve Life Sciences, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Achieve Life Sciences
Historical stock prices
Current Share PriceUS$3.34
52 Week HighUS$9.42
52 Week LowUS$3.25
Beta1.19
1 Month Change-28.17%
3 Month Change-31.56%
1 Year Change-61.25%
3 Year Change-88.94%
5 Year Change-99.18%
Change since IPO-99.62%

Recent News & Updates

Jun 29

Achieve Life Sciences begins phase 2 trial testing cytisinicline for nicotine e-cigarette cessation

Achieve Life Sciences (NASDAQ:ACHV) said it had begun screening subjects in a Phase 2 clinical trial for nicotine e-cigarette cessation. The mid-stage trial, dubbed ORCA-V1, will evaluate the efficacy and safety of 3mg cytisinicline dosed 3 times daily vs. placebo in about 150 adult e-cigarette users at 5 clinical trial locations in the United States. The company's trial is being supported by the National Institute on Drug Abuse (NIDA) of the National Institutes of Health through grant funding which was awarded in two phases totaling $2.8M.

Shareholder Returns

ACHVUS BiotechsUS Market
7D-20.5%2.9%-2.0%
1Y-61.3%-24.2%-20.3%

Return vs Industry: ACHV underperformed the US Biotechs industry which returned -27.4% over the past year.

Return vs Market: ACHV underperformed the US Market which returned -22.1% over the past year.

Price Volatility

Is ACHV's price volatile compared to industry and market?
ACHV volatility
ACHV Average Weekly Movement7.6%
Biotechs Industry Average Movement11.1%
Market Average Movement6.9%
10% most volatile stocks in US Market15.8%
10% least volatile stocks in US Market2.8%

Stable Share Price: ACHV is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: ACHV's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a16John Bencichhttps://www.achievelifesciences.com

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol.

Achieve Life Sciences, Inc. Fundamentals Summary

How do Achieve Life Sciences's earnings and revenue compare to its market cap?
ACHV fundamental statistics
Market CapUS$32.34m
Earnings (TTM)-US$31.88m
Revenue (TTM)n/a

0.0x

P/S Ratio

-1.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ACHV income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other ExpensesUS$31.88m
Earnings-US$31.88m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-3.29
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio117.4%

How did ACHV perform over the long term?

See historical performance and comparison